Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 82,154 | 79,545 | 77,413 | 66,402 | 70,571 |
| Cost of Goods | 7,851 | 11,696 | 8,380 | 6,539 | 9,417 |
| Gross Profit | 74,303 | 67,849 | 69,033 | 59,863 | 61,154 |
| Operating Expenses | 147,300 | 110,944 | 108,247 | 113,457 | 126,406 |
| Operating Income | -72,146 | -42,399 | -38,834 | -53,055 | -64,835 |
| Interest Expense | 8,164 | 8,165 | 8,150 | 7,992 | 8,277 |
| Other Income | 14 | 88 | 284 | -3,035 | -482 |
| Pre-tax Income | -80,296 | -50,476 | -46,700 | -64,082 | -73,594 |
| Income Tax | 2,981 | -182 | 4,525 | 1,582 | -2,193 |
| Net Income Continuous | -83,277 | -50,294 | -51,225 | -65,664 | -71,401 |
| Net Income | $-83,277 | $-50,294 | $-51,225 | $-65,664 | $-71,401 |
| EPS Basic Total Ops | -0.29 | -0.19 | -0.19 | -0.25 | -0.27 |
| EPS Basic Continuous Ops | -0.29 | -0.19 | -0.19 | -0.25 | -0.27 |
| EPS Diluted Total Ops | -0.29 | -0.19 | -0.19 | -0.25 | -0.27 |
| EPS Diluted Continuous Ops | -0.29 | -0.19 | -0.19 | -0.25 | -0.27 |
| EBITDA(a) | $-69,990 | $-40,227 | $-36,622 | $-50,896 | $-61,618 |